Diagnosis of deep vein thrombosis of the upper extremity: a systematic review and meta-analysis of test accuracy.


Journal

Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425

Informations de publication

Date de publication:
09 06 2020
Historique:
received: 26 12 2019
accepted: 30 04 2020
entrez: 9 6 2020
pubmed: 9 6 2020
medline: 11 5 2021
Statut: ppublish

Résumé

Upper extremity deep vein thrombosis (UEDVT) accounts for ≤10% of DVT and can be associated with morbidity and mortality. Accurate diagnosis and treatment are necessary for safe and effective patient management. We systematically reviewed the accuracy of D-dimer and duplex ultrasonography (US) for the evaluation of suspected first-episode UEDVT. We searched the Cochrane Central Register, OVID MEDLINE, EMBASE, and PubMed for eligible studies, reference lists of relevant reviews, registered trials, and relevant conference proceedings. We included prospective cross-sectional and cohort studies that evaluated test accuracy. Two investigators independently screened and collected data. The risk of bias was assessed using Quality Assessment of Diagnostic Accuracy Studies 2 and certainty of evidence using the Grading of Recommendations Assessment, Development and Evaluation framework. We pooled estimates of sensitivity and specificity. The review included 9 studies. The pooled estimates for D-dimer sensitivity and specificity were 0.96 (95% confidence interval [CI], 0.87-0.99) and 0.47 (95% CI, 0.43-0.52), respectively. The pooled estimates for duplex US sensitivity and specificity were 0.87 (95% CI, 0.73-0.94) and 0.85 (95% CI, 0.72-0.93), respectively. Certainty of evidence was moderate. In this review, we summarized the test accuracy (sensitivity and specificity) of D-dimer and duplex US for this indication. The sensitivity and specificity of the tests found in the present review should be considered in the context of whether they are used alone or in combination, which is dependent on the prevalence of disease in the population, the clinical setting in which the patient is being evaluated, cost, potential harms, and patient outcomes. This study was registered at PROSPERO as Systematic Review Registration Number CRD42018098488.

Identifiants

pubmed: 32511715
pii: S2473-9529(20)31278-7
doi: 10.1182/bloodadvances.2019001409
pmc: PMC7284086
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2516-2522

Informations de copyright

© 2020 by The American Society of Hematology.

Références

Semin Thromb Hemost. 2002 Feb;28(1):89-99
pubmed: 11885029
Thromb Res. 2010 Sep;126(3):195-9
pubmed: 20580416
Clin Sci (Lond). 1998 Jun;94(6):657-61
pubmed: 9854465
Ann Intern Med. 2011 Oct 18;155(8):529-36
pubmed: 22007046
Thromb Haemost. 2008 Jan;99(1):202-7
pubmed: 18217155
Thromb Res. 2015 Apr;135(4):673-8
pubmed: 25700619
ACP J Club. 2008 Dec 16;149(6):2
pubmed: 19071869
Blood Coagul Fibrinolysis. 2006 Apr;17(3):225-6
pubmed: 16575263
BMJ. 2008 May 17;336(7653):1106-10
pubmed: 18483053
Ann Intern Med. 2014 Apr 1;160(7):451-7
pubmed: 24687068
Br J Radiol. 1991 Sep;64(765):777-81
pubmed: 1913037
Surgery. 1982 May;91(5):582-5
pubmed: 7071746
J Clin Oncol. 2003 Oct 1;21(19):3665-75
pubmed: 14512399
Ann Intern Med. 2002 Jun 18;136(12):865-72
pubmed: 12069560
Clin Radiol. 1995 Oct;50(10):687-9
pubmed: 7586960
Blood Adv. 2018 Nov 27;2(22):3226-3256
pubmed: 30482764
J Vasc Surg. 1991 Mar;13(3):391-7
pubmed: 1999858
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
BMJ. 2014 Mar 10;348:g1340
pubmed: 24615063
Arch Intern Med. 1997 Jan 13;157(1):57-62
pubmed: 8996041
J Thromb Haemost. 2005 Nov;3(11):2409-19
pubmed: 15975139

Auteurs

Payal Patel (P)

Department of Emergency Medicine, University of Illinois at Chicago, Chicago, IL.

Cody Braun (C)

Department of Medicine, Loyola University Medical Center, Maywood, IL.

Parth Patel (P)

Department of Medicine, University of Missouri, Kansas City, MS.

Meha Bhatt (M)

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.

Housne Begum (H)

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.

Wojtek Wiercioch (W)

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.

Jamie Varghese (J)

Department of Medicine, University of Missouri, Kansas City, MS.

David Wooldridge (D)

Department of Medicine, University of Missouri, Kansas City, MS.

Hani J Alturkmani (HJ)

Department of Medicine, University of Missouri, Kansas City, MS.

Merrill Thomas (M)

Department of Medicine, University of Missouri, Kansas City, MS.

Mariam Baig (M)

Department of Medicine, University of Missouri, Kansas City, MS.

Waled Bahaj (W)

Department of Medicine, University of Missouri, Kansas City, MS.

Rasha Khatib (R)

Advocate Research Institute, Advocate Health Care, Oak Lawn, IL.

Rohan Kehar (R)

Division of Hematology, Western University, London, ON, Canada.

Rakesh Ponnapureddy (R)

Department of Medicine, University of Missouri, Kansas City, MS.

Anchal Sethi (A)

Department of Medicine, University of Missouri, Kansas City, MS.

Ahmad Mustafa (A)

Department of Medicine, University of Missouri, Kansas City, MS.

Wendy Lim (W)

Department of Medicine and.
Department of Pathology & Molecular Medicine, McMaster University, Hamilton, ON, Canada.

Grégoire Le Gal (G)

Department of Medicine, University of Ottawa, Ottawa Hospital Research Institute, Ottawa, ON, Canada.

Shannon M Bates (SM)

Department of Medicine and.
Thrombosis and Atherosclerosis Research Institute (TaARI), McMaster University, Hamilton, ON, Canada.

Eddy Lang (E)

Department of Emergency Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.

Marc Righini (M)

Division of Angiology and Hemostasis, Department of Medical Specialties, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.

Nedaa M Husainat (NM)

Division of Nephrology and Hypertension, Department of Medicine, University of Kansas Medical Center, Kansas City, KS; and.

Mohamad A Kalot (MA)

Division of Nephrology and Hypertension, Department of Medicine, University of Kansas Medical Center, Kansas City, KS; and.

Yazan Nayif Al Jabiri (YN)

The Specialty Hospital Jaber Ibn Hayyan St. Shmeisani, Amman, Jordan.

Robby Nieuwlaat (R)

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.

Holger J Schünemann (HJ)

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.
Department of Medicine and.

Reem A Mustafa (RA)

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.
Division of Nephrology and Hypertension, Department of Medicine, University of Kansas Medical Center, Kansas City, KS; and.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH